Compositions and methods for treating blood cancer

EP4750458A1Pending Publication Date: 2026-06-03DUKE UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
DUKE UNIV
Filing Date
2024-07-24
Publication Date
2026-06-03

Smart Images

  • Figure US2024039226_30012025_PF_FP_ABST
    Figure US2024039226_30012025_PF_FP_ABST
Patent Text Reader

Abstract

Described herein are compositions and methods for treating, ameliorating, or inhibiting the progress of blood cancer in a cell or a subject. In some embodiments, the compositions and methods comprise one or more retinoid X receptor (RXR) modulators and one or more immunomodulatory agents. In some embodiments, the blood cancer is multiple myeloma (MM). In some embodiments, the subject has diabetes, dyslipidemia, or a combination thereof.
Need to check novelty before this filing date? Find Prior Art